Quantum Biopharma Class B Subordinate Voting Shares
QNTM
28 hedge funds and large institutions have $1.97M invested in Quantum Biopharma Class B Subordinate Voting Shares in 2026 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
144% more capital inflows, than outflows
Capital inflows: $727K | Capital outflows: $298K
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
8% more funds holding
Funds holding: 26 → 28 (+2)
3.49% more ownership
Funds ownership: 10.88% → 14.37% (+3.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AdvisorShares Investments
Bethesda,
Maryland
|
+$656K |
| 2 |
Steward Partners Investment Advisory
New York
|
+$43.5K |
| 3 |
Citigroup
New York
|
+$19.5K |
| 4 |
Atlantic Union Bankshares
Glen Allen,
Virginia
|
+$3.33K |
| 5 |
Delta Asset Management
Memphis,
Tennessee
|
+$1.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$175K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$111K |
| 3 |
Global Retirement Partners
San Rafael,
California
|
-$10.9K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$690 |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$123 |
QNTM Hedge Fund Activity: Q3 2026 in Review
28 of the 8,221 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q3 2026, worth a combined $1.97M — up 31% from $1.5M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new QNTM positions and 4 closed out — a net gain of 2 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was AdvisorShares Investments, adding an estimated $656K. The largest seller was Jane Street, exiting entirely with an estimated $175K sold.
- 28 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q3 2026, up from 26 in Q2 2026.
- Funds reported $1.97M of Quantum Biopharma Class B Subordinate Voting Shares stock for Q3 2026, up 31% quarter-over-quarter.
- 6 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q3 2026 and 4 closed out, a net change of +2 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q3 2026 was AdvisorShares Investments, an estimated $656K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q3 2026 was Jane Street, an estimated $175K sold.
Based on aggregated 13F filings for Q3 2026.